Augmedics’ Novel Financing: Finding Money Close to Home

article image

Augmedics was on the way to a round of financing that would fund commercial launch of its augmented reality surgical guidance technology. Then COVID-19 hit. To the rescue: the company’s US employees who helped fill out the most recent round.

Launched in 2014, Augmedics is an Israeli start-up with a novel augmented (AR) reality surgical guidance technology and ambitious plans. Last September, the company had established an office near Chicago and had hired about 20 people, all in anticipation of a commercial launch in the first quarter of 2020 following FDA clearance of its flagship technology, the xvision Spine system.  

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to MedTech Strategist:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to MedTech Strategist
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite


We're here to help! Please contact us at: